Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Deals & Financings

VC fundings, mergers and acquisitions, and other financing events...

Ocumension Stages $184 Million HK IPO; Climbs 152% on First Day

Harbour BioMed Closes $103 Million Financing for Biologic Portfolio

Clover Bio Raises $66 Million from CEPI for Trimer-Tag COVID-19 Vaccine

OBiO Raises $28 Million for Viral Vector CRO/CDMO Operations

Zai Lab In-licenses NSCLC Candidate from Turning Point in $178 Million Deal

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China